However, in our opinion, given the uncertainties about the effect of a prolonged, albeit asymptomatic, hyperprolactinemia during development, a baseline PRL, a monthly clinical monitoring of PRL-related symptoms, and periodic PRL assessments (twice per year) are warranted. The gene discussed is PRL; the disease is hyperprolactinemia.